Asia Pacific Cancer Vaccines Market Key Players and Forecast by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Asia Pacific Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography

Report Date : Oct 2020
Report Code : TIPRE00015127

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 174

Page Updated: Oct 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Asia Pacific cancer vaccines market was valued at US$ 861.55 million in 2019 and is projected to reach US$ 3,131.09 million by 2027; it is expected to grow at a CAGR of 17.9% during the forecast period.

The growth of the Asia Pacific Cancer Vaccines market is mainly attributed to the growing prevalence of cancer and initiatives taken by global health organization.

In Asia Pacific, China is the largest market for cancer vaccines market. The growth of the market is primarily attributed to the growing biotechnology market, increasing developments by the market players, and favorable regulatory policies. The excessive population in China coupled with the rise of cancer prevalence is majorly driving the growth of the cancer vaccines in China and making it a prime market in the Asia Pacific region.

In addition, in the last few years, the companies in china are undergoing collaborations, partnerships and mergers to advance the cancer vaccines technology. For instance, Researchers from Queen Mary University of London and Zhengzhou University collaborated to develop a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. The research was funded by the Chinese Ministry of Science and Technology and Zhengzhou University and was published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

China Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)

ASIA PACIFIC CANCER VACCINES – MARKET SEGMENTATION

By Technology

Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen Cancer Vaccines
Whole Cell Cancer Vaccines
Viral Vector Cancer Vaccines

By Type

Preventive Cancer Vaccines
Therapeutic Cancer Vaccine

By Indication

Cervical Cancer
Prostate Cancer
Other Indications

By End Use

Pediatrics
Adults

By Country

US
Canada
Mexico

Company Profiles

AstraZeneca
GlaxoSmithKline plc.
Aduro Biotech Inc
Pfizer Inc.
Sanofi
Bristol-Myers Squibb
Moderna, Inc.
OncBioMune Pharmaceuticals Inc.
MaxiVAX
Nouscom

Asia Pacific Cancer Vaccines Report Scope

Report Attribute	Details
Market size in 2019	US$ 861.55 Million
Market Size by 2027	US$ 3,131.09 Million
Global CAGR (2019 - 2027)	17.9%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Technology Dendritic Cells Cancer Vaccines Recombinant Cancer Vaccines Antigen Cancer Vaccines Whole Cell Cancer Vaccines Viral Vector Cancer Vaccines By Type Preventive Cancer Vaccines Therapeutic Cancer Vaccines By Indication Cervical Cancer Prostate Cancer Other Indications By End User Pediatrics Adults
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	AstraZeneca GlaxoSmithKline plc. Aduro Biotech Inc Pfizer Inc. Sanofi Bristol-Myers Squibb Moderna, Inc. OncBioMune Pharmaceuticals Inc. MaxiVAX

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Asia Pacific Cancer Vaccines Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy